Oxadiazoles in Medicinal Chemistry

被引:529
|
作者
Bostrom, Jonas [1 ]
Hogner, Anders [1 ]
Llinas, Antonio [1 ]
Wellner, Eric [1 ]
Plowright, Alleyn T. [1 ]
机构
[1] AstraZeneca R&D, S-43183 Molndal, Sweden
关键词
DRUG-LIKE PROPERTIES; RECEPTOR ANTAGONISTS; CARBOXYLIC-ACIDS; DISCOVERY; 1,3,4-OXADIAZOLES; INHIBITORS; LIPOPHILICITY; PHARMACOLOGY; REPLACEMENTS; SELECTIVITY;
D O I
10.1021/jm2013248
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Oxadiazoles are five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom, and they exist in different regioisomeric forms. Oxadiazoles are frequently occurring motifs in druglike molecules, and they are often used with the intention of being bioisosteric replacements for ester and amide functionalities. The current study presents a systematic comparison of 1,2,4- and 1,3,4-oxadiazole matched pairs in the AstraZeneca compound collection. In virtually all cases, the 1,3,4-oxadiazole isomer shows an order of magnitude lower lipophilicity (log D), as compared to its isomeric partner. Significant differences are also observed with respect to metabolic stability, hERG inhibition, and aqueous solubility, favoring the 1,3,4-oxadiazole isomers. The difference in profile between the 1,2,4 and 1,3,4 regioisomers can be rationalized by their intrinsically different charge distributions (e.g., dipole moments). To facilitate the use of these heteroaromatic rings, novel synthetic routes for ready access of a broad spectrum of 1,3,4-oxadiazoles, under mild conditions, are described.
引用
收藏
页码:1817 / 1830
页数:14
相关论文
共 50 条
  • [1] The Evolution of Medicinal Chemistry
    Bowen, J. Phillip
    Zhong, Haizhen A.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (09) : 897 - 898
  • [2] Adventures in Medicinal Chemistry: A Career in Drug Discovery
    Greenlee, William J.
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 11 - 23
  • [3] Technical Advances in Medicinal Chemistry
    不详
    ACS COMBINATORIAL SCIENCE, 2017, 19 (05) : 277 - 278
  • [4] Polyfluorinated groups in medicinal chemistry
    Bassetto, Marcella
    Ferla, Salvatore
    Pertusati, Fabrizio
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (04) : 527 - 546
  • [5] Spirocyclic Scaffolds in Medicinal Chemistry
    Hiesinger, Kerstin
    Dar'in, Dmitry
    Proschak, Ewgenij
    Krasavin, Mikhail
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (01) : 150 - 183
  • [6] Zinc enzymes in medicinal chemistry
    Hou, Rui
    He, Yan
    Yan, Guangwei
    Hou, Shuzeng
    Xie, Zhouling
    Liao, Chenzhong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 226
  • [7] Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective
    Sautier, Brice
    Nising, Carl F.
    Wortmann, Lars
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2016, 55 (52) : 15982 - 15988
  • [8] Benzoxazoles and oxazolopyridines in medicinal chemistry studies
    Demmer, Charles S.
    Bunch, Lennart
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 97 : 778 - 785
  • [9] Chemistry, Pharmaceutical and Medicinal Chemistry, Pharmacology, Biochemistry and Molecular Biology
    Soniya, Naik
    Soumya, Vasu
    Shivlingrao, Mamle Desai
    Manickavasagam, M.
    Meeramol, Chellappan
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024,
  • [10] Oxazolidinones as versatile scaffolds in medicinal chemistry
    Fernandes, Guilherme Felipe Santos
    Scarim, Caue Benito
    Kim, Seong-Heun
    Wu, Jingyue
    Castagnolo, Daniele
    RSC MEDICINAL CHEMISTRY, 2023, 14 (05): : 823 - 847